Attorneys general from West Virginia, Ohio, and 42 other states have filed an antitrust lawsuit against 20 of the nation’s largest generic drug manufacturers.
The lawsuit, filed in US District Court in Connecticut, accuses the drugmakers of a conspiracy to “artificially inflate and manipulate prices, reduce competition and unreasonably restrain trade” for more than 100 generic drugs.
“The allegations that we have included in the complaint, when proven, are illegal and those who participated in this type of conspiracy must be held accountable,” West Virginia Attorney General Morrisey said.
“Antitrust violations drive up prices for the consumer and, in this instance, it impacts those in desperate need of prescription drugs.”
Authorities said the drugs at issue account for billions of dollars of sales in the United States and that the alleged schemes increased prices affecting the health-insurance market, health-care programs like Medicare and Medicaid, and individuals who must pay artificially-inflated prices for their prescriptions drugs, Ohio Attorney General Dave Yost said in a news release.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
FTC Moves to Ban Non-Compete Agreements, Aiming to Boost Labor Mobility
Apr 23, 2024 by
CPI
Federal Judge Nods at $418M Deal in Real Estate Antitrust Suit
Apr 23, 2024 by
CPI
Mexican Watchdog Probes Amazon and Mercado Libre Over Loyalty Bundles
Apr 23, 2024 by
CPI
Competition Commission of India to Probe AI Landscape for Competition
Apr 23, 2024 by
CPI
Canada’s Agricultural Giants in Antitrust Spotlight
Apr 23, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI